Emcure Pharma Review: Jefferies, Kotak Maintain Buy; Raise Growth Estimates

Emcure Pharmaceuticals' Q2 performance and improving growth outlook have prompted Jefferies and Kotak to maintain their Buy ratings.
More news in Trending
'Let Him Play Domestic Cricket': Team India Sent Message Over Star Spinner's Snub
Soni Razdan Says Bursting Firecrackers On Diwali Is 'Anti-National'
Novak Djokovic Comes From Behind To Beat Valentin Vacherot In Paris Masters
US Midterm Election Result: When Will Vote Counting End In Key Senate States?
Could Russell Wilson Make A Shock Move To NC State?